CVB Notice 23-15: Issuance of a Conditional License for Rabbit Hemorrhagic Disease Virus

USDA APHIS Header


Having trouble viewing this email? View it as a Web page. Bookmark and Share

The Center for Veterinary Biologics (CVB) recently added CVB Notice 23-15: Issuance of a Conditional License for Rabbit Hemorrhagic Disease Virus to its website. The Animal and Plant Health Inspection Service (APHIS) has issued a conditional United States Veterinary Biological Product License to Medgene Labs, Establishment No. 474, Brookings, South Dakota, for the manufacture and distribution of Rabbit Hemorrhagic Disease Vaccine, Serotype 2, Killed Baculovirus Vector. 

***

Please share the following link with others who may be interested in these updates. Click here to subscribe to the VS Animal Health Stakeholder Registry. This link will also allow you to change or cancel your subscriptions.